Cargando…

Proteomics Characterization of Clear Cell Renal Cell Carcinoma

Purpose: To explore the tumor proteome of patients diagnosed with localized clear cell renal cancer (ccRCC) and treated with surgery. Material and methods: A total of 165 FFPE tumor samples from patients diagnosed with ccRCC were analyzed using DIA-proteomics. Proteomics ccRCC subtypes were defined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranda-Poma, Jesús, Trilla-Fuertes, Lucía, López-Vacas, Rocío, López-Camacho, Elena, García-Fernández, Eugenia, Pertejo, Ana, Lumbreras-Herrera, María I., Zapater-Moros, Andrea, Díaz-Almirón, Mariana, Dittmann, Antje, Fresno Vara, Juan Ángel, Espinosa, Enrique, González-Peramato, Pilar, Pinto-Marín, Álvaro, Gámez-Pozo, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821535/ https://www.ncbi.nlm.nih.gov/pubmed/36615183 http://dx.doi.org/10.3390/jcm12010384

Ejemplares similares

miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

Bayesian networks established functional differences between breast cancer subtypes
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

Melanoma proteomics suggests functional differences related to mutational status
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2019)

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
por: Prado-Vázquez, Guillermo, et al.
Publicado: (2019)

Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2022)

Molecular characterization of breast cancer cell response to metabolic drugs
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2018)

Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer
por: Zapater-Moros, Andrea, et al.
Publicado: (2018)

A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities
por: López-Camacho, Elena, et al.
Publicado: (2023)

Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2019)

Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer
por: Rojas L, Katerin, et al.
Publicado: (2019)

Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics
por: Gámez-Pozo, Angelo, et al.
Publicado: (2017)

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2023)

Functional proteomics outlines the complexity of breast cancer molecular subtypes
por: Gámez-Pozo, Angelo, et al.
Publicado: (2017)

Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

Urothelial cancer proteomics provides both prognostic and functional information
por: de Velasco, Guillermo, et al.
Publicado: (2017)

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases
por: Laimito, Katerin Rojas, et al.
Publicado: (2016)

PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics
por: Gámez-Pozo, Angelo, et al.
Publicado: (2012)

Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2021)

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2023)

An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer
por: Sánchez-Navarro, Iker, et al.
Publicado: (2010)

Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma
por: Albiñana, Virginia, et al.
Publicado: (2022)

Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel–Lindau Disease
por: Albiñana, Virginia, et al.
Publicado: (2020)

MALDI Profiling of Human Lung Cancer Subtypes
por: Gámez-Pozo, Angelo, et al.
Publicado: (2009)

microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples
por: Gámez-Pozo, A, et al.
Publicado: (2011)

The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+ Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy
por: Gámez-Pozo, Angelo, et al.
Publicado: (2014)

Comparison of Prognostic Gene Profiles Using qRT-PCR in Paraffin Samples: A Retrospective Study in Patients with Early Breast Cancer
por: Espinosa, Enrique, et al.
Publicado: (2009)

Towards Personalized Sampling in Clear Cell Renal Cell Carcinomas
por: Manini, Claudia, et al.
Publicado: (2022)

Nuclear and cytosolic pS727-STAT3 levels correlate with overall survival of patients affected by clear cell renal cell carcinoma (ccRCC)
por: Arévalo, Jazmine, et al.
Publicado: (2021)

Pathology and the evolutionary dynamics of clear cell renal cell carcinoma
por: Manini, Claudia, et al.
Publicado: (2022)

Snail heterogeneity in clear cell renal cell carcinoma
por: Zaldumbide, Laura, et al.
Publicado: (2016)

Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage
por: Laso-García, Fernando, et al.
Publicado: (2023)

Updating Clear Cell Renal Cell Carcinoma (a Tribute to Prof. Ondrej Hes)
por: Manini, Claudia, et al.
Publicado: (2022)

The renal clear cell carcinoma immune landscape
por: Saad, Omar A., et al.
Publicado: (2022)

Thyroid metastasis as initial presentation of clear cell renal carcinoma
por: Ramírez-Plaza, César Pablo, et al.
Publicado: (2015)

The role of immunotherapy in non-clear cell renal cell carcinoma
por: Climent, Carla, et al.
Publicado: (2023)

pVHL-mediated regulation of the anti-angiogenic protein thrombospondin-1 decreases migration of Clear Cell Renal Carcinoma Cell Lines
por: Sevilla-Montero, Javier, et al.
Publicado: (2020)

Cytologic features of metanephric adenoma of the kidney
por: Jiménez-Heffernan, José A., et al.
Publicado: (2009)

Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
por: Doppalapudi, Sai Krishnaraya, et al.
Publicado: (2021)

Honey: Another Alternative in the Fight against Antibiotic-Resistant Bacteria?
por: Combarros-Fuertes, Patricia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4d3h46d40ic798pjoflacivjsp